Trit Garg1, Laurence C Baker2, Matthew W Mell1. 1. Division of Vascular Surgery, Stanford School of Medicine, Stanford, California. 2. Department of Health Research and Policy, Stanford School of Medicine, Stanford, California3National Bureau of Economic Research, Cambridge, Massachusetts.
Abstract
IMPORTANCE: The Society for Vascular Surgery recommends annual surveillance with computed tomography (CT) or ultrasonography after endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysms. However, such lifelong surveillance may be unnecessary for most patients, thereby contributing to overuse of imaging services. OBJECTIVE: To investigate whether nonadherence to Society for Vascular Surgery-recommended surveillance guidelines worsens long-term outcomes after EVAR among Medicare beneficiaries. DESIGN, SETTING, AND PARTICIPANTS: We collected data from Medicare claims from January 1, 2002, through December 31, 2011. A total of 9503 patients covered by fee-for-service Medicare who underwent EVAR from January 1, 2002, through December 31, 2005, were categorized as receiving complete or incomplete surveillance. We performed logistic regressions controlling for patient demographic and hospital characteristics. Patients were then matched by propensity score with adjusting for all demographic variables, including age, sex, race, Medicaid eligibility, residential status, hospital volume, ruptured abdominal aortic aneurysms, and all preexisting comorbidities. We then calculated differences in long-term outcomes after EVAR between adjusted groups. Data analysis was performed from January 1, 2002, through December 31, 2011. MAIN OUTCOMES AND MEASURES: Post-EVAR imaging modality, aneurysm-related mortality, late rupture, and complications. RESULTS: Median follow-up duration was 6.1 years. Incomplete surveillance was observed in 5526 of 9695 patients (57.0%) who survived the initial hospital stay at a mean (SD) of 5.2 (2.9) years after EVAR. After propensity matching, our cohort consisted of 7888 patients, among whom 3944 (50.0%) had incomplete surveillance. For those in the matched cohort, patients with incomplete surveillance had a lower incidence of late ruptures (26 of 3944 [0.7%] vs 57 of 3944 [1.4%]; P = .001) and major or minor reinterventions (46 of 3944 [1.2%] vs 246 of 3944 [6.2%]; P < .001) in unadjusted analysis. Aneurysm-related mortality was not statistically different between groups (13 of 3944 [0.3%] vs 24 of 3944 [0.6%]; P = .07). In adjusted analysis of postoperative outcomes controlling for all patient and hospital factors by the tenth postoperative year, patients in the incomplete surveillance group experienced lower rates of total complications (2.1% vs 14.0%; P < .001), late rupture (1.1% vs 5.3%; P < .001), major or minor reinterventions (1.4% vs 10.0%; P < .001), aneurysm-related mortality (0.4% vs 1.3%; P < .001), and all-cause mortality (30.9% vs 68.8%, P < .001). CONCLUSIONS AND RELEVANCE: Nonadherence to the Society for Vascular Surgery guidelines for post-EVAR imaging was not associated with poor outcomes, suggesting that, in many patients, less frequent surveillance is not associated with worse outcomes. Improved criteria for defining optimal surveillance will achieve higher value in aneurysm care.
IMPORTANCE: The Society for Vascular Surgery recommends annual surveillance with computed tomography (CT) or ultrasonography after endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysms. However, such lifelong surveillance may be unnecessary for most patients, thereby contributing to overuse of imaging services. OBJECTIVE: To investigate whether nonadherence to Society for Vascular Surgery-recommended surveillance guidelines worsens long-term outcomes after EVAR among Medicare beneficiaries. DESIGN, SETTING, AND PARTICIPANTS: We collected data from Medicare claims from January 1, 2002, through December 31, 2011. A total of 9503 patients covered by fee-for-service Medicare who underwent EVAR from January 1, 2002, through December 31, 2005, were categorized as receiving complete or incomplete surveillance. We performed logistic regressions controlling for patient demographic and hospital characteristics. Patients were then matched by propensity score with adjusting for all demographic variables, including age, sex, race, Medicaid eligibility, residential status, hospital volume, ruptured abdominal aortic aneurysms, and all preexisting comorbidities. We then calculated differences in long-term outcomes after EVAR between adjusted groups. Data analysis was performed from January 1, 2002, through December 31, 2011. MAIN OUTCOMES AND MEASURES: Post-EVAR imaging modality, aneurysm-related mortality, late rupture, and complications. RESULTS: Median follow-up duration was 6.1 years. Incomplete surveillance was observed in 5526 of 9695 patients (57.0%) who survived the initial hospital stay at a mean (SD) of 5.2 (2.9) years after EVAR. After propensity matching, our cohort consisted of 7888 patients, among whom 3944 (50.0%) had incomplete surveillance. For those in the matched cohort, patients with incomplete surveillance had a lower incidence of late ruptures (26 of 3944 [0.7%] vs 57 of 3944 [1.4%]; P = .001) and major or minor reinterventions (46 of 3944 [1.2%] vs 246 of 3944 [6.2%]; P < .001) in unadjusted analysis. Aneurysm-related mortality was not statistically different between groups (13 of 3944 [0.3%] vs 24 of 3944 [0.6%]; P = .07). In adjusted analysis of postoperative outcomes controlling for all patient and hospital factors by the tenth postoperative year, patients in the incomplete surveillance group experienced lower rates of total complications (2.1% vs 14.0%; P < .001), late rupture (1.1% vs 5.3%; P < .001), major or minor reinterventions (1.4% vs 10.0%; P < .001), aneurysm-related mortality (0.4% vs 1.3%; P < .001), and all-cause mortality (30.9% vs 68.8%, P < .001). CONCLUSIONS AND RELEVANCE: Nonadherence to the Society for Vascular Surgery guidelines for post-EVAR imaging was not associated with poor outcomes, suggesting that, in many patients, less frequent surveillance is not associated with worse outcomes. Improved criteria for defining optimal surveillance will achieve higher value in aneurysm care.
Authors: Jesse A Columbo; Art Sedrakyan; Jialin Mao; Andrew W Hoel; Spencer W Trooboff; Ravinder Kang; Jeremiah R Brown; Philip P Goodney Journal: J Vasc Surg Date: 2019-03-25 Impact factor: 4.268
Authors: Caitlin W Hicks; Devin S Zarkowsky; Ian C Bostock; David H Stone; James H Black; Jens Eldrup-Jorgensen; Philip P Goodney; Mahmoud B Malas Journal: J Vasc Surg Date: 2017-02-16 Impact factor: 4.268
Authors: Benjamin S. Brooke; Adam W. Beck; Larry W. Kraiss; Andrew W. Hoel; Andrea M. Austin; Amir A. Ghaffarian; Jack L. Cronenwett; Philip P. Goodney Journal: JAMA Surg Date: 2018-03-01 Impact factor: 14.766
Authors: Jesse A Columbo; Ravinder Kang; Andrew W Hoel; Jeanwan Kang; Kathleen A Leinweber; Karissa S Tauber; Regis Hila; Niveditta Ramkumar; Art Sedrakyan; Philip P Goodney Journal: J Vasc Surg Date: 2018-06-15 Impact factor: 4.268
Authors: Elizabeth A Andraska; Amanda R Phillips; Katherine M Reitz; Sina Asaadi; Yancheng Dai; Edith Tzeng; Michel Makaroun; Nathan Liang Journal: J Vasc Surg Date: 2022-01-29 Impact factor: 4.860
Authors: Jesse A Columbo; Ravinder Kang; Spencer W Trooboff; Kristen S Jahn; Camilo J Martinez; Kayla O Moore; Andrea M Austin; Nancy E Morden; Corinne G Brooks; Jonathan S Skinner; Philip P Goodney Journal: Circ Cardiovasc Qual Outcomes Date: 2018-10
Authors: Jesse A Columbo; Niveditta Ramkumar; Pablo Martinez-Camblor; Ravinder Kang; Bjoern D Suckow; A James O'Malley; Art Sedrakyan; Philip P Goodney Journal: J Vasc Surg Date: 2019-08-27 Impact factor: 4.268
Authors: Matthew Joe Grima; Mourad Boufi; Martin Law; Dan Jackson; Kate Stenson; Benjamin Patterson; Ian Loftus; Matt Thompson; Alan Karthikesalingam; Peter Holt Journal: Eur J Vasc Endovasc Surg Date: 2018-01-05 Impact factor: 7.069
Authors: Spencer W Trooboff; Zachary J Wanken; Barbara Gladders; Jesse A Columbo; Jon D Lurie; Philip P Goodney Journal: Circ Cardiovasc Qual Outcomes Date: 2020-05-07